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The brain derived neurotrophic factor (BDNF) is a neurotrophin that plays an important role in the cell survival, axonal and dendritic 
growth, and synaptic plasticity. BDNF gene polymorphisms, functional Val66Met mainly, were shown to influence human brain structure 
and cognition. 
The aim of the study was to assess the relationship between twelve BDNF gene variants and their haplotypes and cognitive performance 
measured using the Wisconsin Card Sorting Test (WCST), the Trail Making Test (TMT), the Stroop Test which are to a large extent connected 
with prefrontal cortex activity. Our sample consisted of 460 healthy participants from Polish population. We detected possible association 
between five BDNF polymorphisms (rs11030101, rs10835210, rs2049046, rs2030324, rs2883187) and TMT_A. Additionally, one haplotype 
block made from eleven BDNF variants (rs2883187, rs1401635, rs2049046, rs2030324, rs11030101, rs10835210, rs1013402, rs1401635, 
rs1013402), as significant linkage disequilibrium appeared. We discovered possible relationships of CACCGCGTACG and CACCGCGTACG 
haplotypes with TMT_A and TMT_B performance respectively. Our results confirmed the involvement of BDNF in the regulation of 
psychomotor speed, working memory and executive function in healthy subjects measured by a task engaging visuoperceptual abilities.
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INTRODUCTION
Research over the past two decades has highlighted the 
relationship of cognitive performance with the system of 
neurotrophins. Neurotrophins are a family of polypeptide 
growth factors with similar structures, involved in 
processes of brain development, differentiation and 
survival of neurons, synaptic plasticity and connectivity 
(Bath and Lee 2006). Neurotrophins group consists of: nerve 
growth factor (NGF), brain-derived neurotrophic factor 
(BDNF), neurotrophin-3 (NT-3), neurotrophin 4/5 (NT-4/5) 
(Barde et al. 1982, Leiberock et al. 1989). BDNF seems to 
play the most important role in the cognitive processes. It 
affects the development and activity of brain structures, 
predominantely hippocampus and prefrontal cortex (Lipska 
et al. 2001), by modulating the synaptic neurotransmission, 
affecting neuronal plasticity and proliferation of nerve cells 
(Figurov et al. 1996, Lu and Gottschalk 2000, Chen et al. 2004), 
and by regulating the processes of neuronal migration, i.e.: 
neuronal differentiation and preservation of modifications 
and changes of synaptic structures (Huang et al. 1999). 
BDNF also influences the development of dopaminergic 
(Altar et al. 1992, Shen et al. 1994), serotoninergic (White et 
al. 1994, Mamounas et al. 2000) cholinergic (Lindsay 1995, 
Lindvall et al. 1994) and GABAergic neurons (Ventimiglia 
et al. 1995). Furthermore, BDNF causes rapid postsynaptic 
reaction on ion channels and NMDA receptors (Levine et 
al. 1995). 
BDNF gene is located on the short arm of chromosome 11 
(Maisonpierre et al. 1991). It has a complex structure and 
regulation of expression. Pruunsild and others (2007) 
determined that the BDNF gene contains 11 exons and 
spans about 70 kb. They identified transcription start 
sites in 9 exons, each of which was associated with 
a functional promoter.
In the position 196 of the nucleotide sequence of 
the 3 ‘exon encoding the BDNF protein, there is a most 
widely studied functional polymorphism A/G, leading to 
the substitution of amino acid of valine to methionine at 
position 66 of the protein (refSNP Cluster Report: rs6265). 
An ancestral allele is Val and frequency of occurrence of 
the Met allele in different populations varies from 0% in © 
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African populations to 70% in Asian populations. In the 
Caucasian population frequency of the Met allele is approx. 
20%. The rate of spread of the Met allele indicates a strong 
evolutionary selection of the genomic region, in which the 
polymorphism is located (Petryshen et al. 2010). 
In recent years, studies have been conducted in order 
to analyze the relationship of Val66Met polymorphism 
with the structural and functional changes in the brain. 
In volumetric studies Met-carriers were found to have 
a hippocampal volume reduction in both healthy cohorts 
and psychiatric patients with schizophrenia, bipolar 
disorder, major depression and anxiety disorders (Pezewas 
et al. 2004, Szeszko et al. 2005, Bueller et al. 2006, Frodl et 
al. 2007, Chepenik et al. 2009, Mueller et al. 2013). These 
observations were confirmed in three meta-analytic 
reviews (Hajek et al. 2012, Kambeitz et al. 2012, Molendijk 
et al. 2012). However, the most recent meta-analyses 
showed no association between Val66Met polymorphism 
and hippocampal volumes neither in healthy subjects nor 
clinical groups (Harrisberger et al. 2014, 2015). The authors 
suggest that inconsistency of the results may be related to 
measuring techniques and sample sizes.
BDNF-dependent differences in structure of different 
cortical regions were also investigated. Healthy 
Met-carriers were found to have bilateral reductions 
of gray matter volumes in frontal lobes, predominately 
dorsolateral prefrontal cortex (Pezawas et al. 2004). It was 
confirmed by Nemoto and others (2006) in healthy subjects 
of the Japanese population who demonstrated a significant 
reduction in volume in the dorsolateral prefrontal cortex 
(DLPFC), moreover in anterior cingulate cortex (ACC), 
temporal lobe and parietal cortex correlated with age. 
These changes were greater in participants with the Met 
allele, mainly in women. Also, in the study of Matsuo 
a and colleagues (2009) the reduced volume of dorsolateral 
prefrontal cortex and anterior cingulate in Val/Met bipolar 
patients compared with Val/Val patients and healthy 
subjects was detected. In addition, Ho and others (2006) in 
a group of healthy American subjects and in patients with 
psychotic symptoms, showed the Met allele association 
with a lower volume of gray matter in the temporal and 
occipital lobes, while in Yang and colleagues (2012) study 
Met healthy adults homozygotes of Chinese population 
had smaller volumes of frontal, temporal, cingulate and 
insular cortices. Moreover, Montag and others (2009) 
found an association between the Met allele and smaller 
parahippocampal volumes, right amygdala, thalamus, 
fusiformus gyrus and several parts of the frontal gyrus 
in the group of healthy Caucasians. In his later study, he 
also revealed an epistasis effect of BDNF and DRD2 genes 
on gray matter volume of ACC. Participants with at least 
one Met allele of the BDNF and one A1 allele of the DRD2 
were observed to have lowest gray matter volume of the 
ACC (Montag et al. 2010). 
Functional neuroimaging studies have also addressed the 
BDNF association with the level of brain activation during 
cognitive performance. Most of the study investigated 
the hippocampus-related cognitive functions of memory 
and learning. The Met allele in heterozygous system was 
associated with abnormalities of the hippocampal and 
prefrontal activation in the course of neuropsychological 
testing (Bath and Lee 2006). In studies of Egan and colleagues 
(2003) Met allele carriers had a weaker hippocampal 
activation associated with poorer episodic memory 
compared to those with Val/Val genotype. Hariri and others 
(2003) when studying declarative memory in healthy adults 
observed the better performance and increased activation 
of the posterior hippocampal formation during encoding 
and retrieval of information in subjects with the Val allele. 
The study of Hashimoto and colleagues (2008) showed no 
effect of the Val66Met polymorphism on episodic memory in 
healthy Japanese subjects, but they observed the association 
of the Met allele with the decreased activity of the bilateral 
hippocampi and right parahippocampal gyrus. Moreover, 
van Wingen and others (2010) using face recognition task 
demonstrated sex-specific BDNF genotype effect on the 
amygdala activation during encoding, and on the prefrontal 
cortex and posterior cingulate cortex activity during memory 
retrieval. A larger contribution of these brain regions to the 
effective memory performance was observed in males with 
the Met allele compared to Val homozygotes, while there 
were no differences in females. The fMRI studies comparing 
the effect of Val66Met polymorphism on working memory in 
healthy subjects and patients with multiple sclerosis indicate 
the Met allele association with increased activation in the 
parieto-prefrontal network with simultaneous deactivation 
of the cortico-limbic regions. These results were obtained 
only in healthy subjects (Cerasa et al. 2010). 
The results of previous research have also reported 
associations of Val66Met polymorphism with cognitive 
performance. Polish studies compared the results of 
Wisconsin Card Sorting Test, a task that is used as a 
standard diagnostic tool of executive functions (such as 
planning and set shifting) in bipolar patients with Val/Val 
and Val/Met genotypes. They revealed the significantly 
worse results in all test parameters in the group of 
patients with methionine allele (Rybakowski et al. 2003). 
In the other study of Rybakowski and colleagues (2006) 
Val homozygotes with schizophrenia have shown better 
performance on the N-back test, a task that measures 
attention and working memory. This relation was not 
observed in patients with bipolar disorder. The research 
of Gong and others (2009) on a large group of healthy 
Chinese young adults showed a better working memory 
for digits and spatial localization in people with Val/Val 
genotype. Similar results were obtained in the Caucasian 
population where Val homozygotes showed better 
associative memory and higher processing speed, with a 
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greater effect occurring in women (Raz et al. 2009). Met 
allele relationship with decreased efficacy of episodic 
memory in healthy subjects was also confirmed by study 
of Dempster and colleagues (2005). In addition, Goldberg 
and others (2008) and Montag and others (2014) found 
healthy Met-carriers compared to Val homozygotes 
presented bigger decline in recognition of previously 
learned verbal material after 24-hour and one-week delay, 
respectively. Moreover, Ho and colleagues (2006) found 
poorer verbal memory both in Met healthy volunteers and 
psychotic patients. The patients exhibited also visuospatial 
impairment. Similarly, in Zhang and others (2012) study, 
schizophrenic subjects and healthy controls with Met 
variant performed worse on visuospatial-constructional 
task. In addition, schizophrenic patients showed attention 
deficits. Furthermore, Val66Met polymorphism was also 
associated with intelligence. The Met carriers obtained 
significantly lower scores on tests of general intelligence, 
both in young Chinese female population (Tsai et al. 2004), 
as well as in older Caucasian adults (Miyajima et al. 2008). 
However, some of the studies have revealed a protective 
role of Met allele against neurocognitive deterioration in 
certain diseases (Oroszi et al. 2006) and in older age (Harris 
et al. 2006, Brooks et al. 2014).
Much lesser is known about the effect of other BDNF 
polymorphisms on brain structure and cognition in 
humans. Cathomas and others (2010) conducted the 
analysis of 55 single nucleotide polymorphisms (SNPs) 
with memory tested on the basis of reproduction of verbal 
material using neutral and emotional words. The results 
have not only confirmed the association of Val66 allele 
with better memory performance, but also reported that 
rs7127239, rs7125904, rs10835190 and rs10835218 reached 
the minimum level of statistical significance, which may 
constitute a prerequisite for their participation in memory 
processes. In turn, Laing and colleagues (2012) assessed 
the relationship of cognitive functions: psychomotor 
speed, attention and memory with rs6265, rs7103411 
and rs7124442 polymorphisms. The results showed the 
relationship between rs7103411 polymorphism and 
memory. Moreover, gender-specific analyzes revealed the 
relationship of rs7103411 and rs6265 polymorphisms with 
psychomotor speed and memory in women. 
Some publications have not found any associations 
between polymorphisms of BDNF gene and cognition. Hansell 
and others (2007) in a large cohort of healthy adolescents 
have found no relation between Va166Met polymorphism 
relation and memory, while Tsai and colleagues (2008) 
in the group of participants in late adulthood did not 
observed any relationship between this polymorphism in 
the normal process of aging and its associated attenuation 
of cognitive function. Meta-analysis of 23 studies on the 
relationship of Val66Met polymorphism with cognition 
showed no significant association with general cognitive 
ability, memory, executive function, visual processing 
and cognitive fluency (Mandelman and Grigorenko 2012). 
However, the authors suggest that further studies on larger, 
ethnically and age homogenous populations, including 
greater amount of BDNF gene polymorphisms, analysis of 
the haplotypes or its interactions with other genes should 
be carried out. 
Therefore, the main goal of the present study was 
to verify the relationship between twelve BDNF gene 
polymorphisms and their haplotype and the results of 
neuropsychological tests connected to large extent with 
the activity of prefrontal cortex in 460 healthy subjects of 
Polish population. 
METHODS
Participants
The study included 460 healthy volunteers (227 males 
and 233 females) aged 18–60 (M=36.18; SD=12.13) without 
history of any psychiatric disorder, substance abuse or 
serious somatic illnesses. All participants were Caucasians 
of Polish origin. We provided the written informed consent. 
Bioethics Committee of Collegium Medicum in Bydgoszcz, 
Nicolaus Copernicus University in Toruń approved the study.
Neuropsychological assessment
We assessed the neuropsychological performance using 
standard tests:
1) Wisconsin Card Sorting Test® Computer Version 4 
(WCST:CV4TM)-Research Edition (Heaton et al. 1993, 
http://www4.parinc.com). This is a widely used task to 
assess working memory, attention, conceptual thinking 
and executive functions of planning and set-shifting. In 
this test on the computer screen four exemplary card are 
presented. Based on a received feedback, the participant 
is asked to sort up to 128 cards appearing on the bottom 
of the computer screen in accordance with applicable, 
changing criteria.
The following parameters were assessed in the test: 
a) the percentage of perseverative errors (%P) – connected 
with inability to change previous set of reaction; b)  the 
percentage of non-perseverative errors (%NP) – connected 
with attention inability to avoid distraction; c) the percentage 
of conceptual level response (%CONC) – connected with 
ability to utilize new information and previous experience 
to plan a conceptual reaction; d) the number of correctly 
completed categories (CC) – a measure of effectiveness of 
cognitive processes involved in the task; e) the number of 
cards to complete first category (1stCAT) – connected with 
an efficacy/speed of formulating logical conception.
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2) Trail Making Test, TMT (Reitan 1955). The test consists 
of two parts, known as TMT_A and TMT_B. Both of them 
consist of 25 circles distributed over a sheet of paper. TMT_A 
task is to draw the lines to connect the numbers (from 1 to 
25) in ascending order, in the shortest time possible. TMT_ B 
task is to connect the circles, but alternating between the 
numbers (from 1 to 13) and letters (from A to L), as quickly 
as possible, keeping the ascending order of numbers 
and letters. TMT_A requires visuoperceptual abilities 
and attentional search of visual field, whereas TMT_B 
reflects working memory, sustained and divided attention, 
and task-switching ability, while TMT B-A indicator by 
minimizing visuoperceptual and working memory demands, 
provides a good measure of executive control abilities and 
cognitive plasticity (Sanchez-Cubillo et al. 2009, Łojek and 
Stańczak, 2012). The time of performance on TMT_A is 
also a good measure of psychomotor speed. Neuroimaging 
data indicated that the performance on the TMT involves 
prefrontal areas of the brain, particularly the dorsolateral 
ones (Shibuya-Tayoshi et al. 2007, Kubo et al. 2008).
The following parameters were assessed in the test: 
a) the time of performance on A (TMT_A) and B parts 
(TMT_B) in seconds; b) the time difference between 
performance on both parts of the test (TMT_B-A) in 
seconds.
3) Stroop Color-Word Interference Test (Stroop 1935). It 
consists of two parts. In the first part (RCNb – Reading Color 
Names in Black) 50 words printed in black, meaning the names 
of seven colors (green, red, blue, pink, yellow, brown, black) 
are presented to the participant. The task is to read loud all 
the words, as quickly as possible. In the second part (NCWD 
– Naming Color of Word – different) the printout of same 
50 names of 7 colors, printed in 4 different colors is presented 
to the subject. The names of colors do not correspond with 
the color of the print (e.g. the word “red” is printed in green). 
The task is to name the color of the print without reading 
what is written. RCNb part assesses the speed of reading – a 
measure of psychomotor speed and NCWd (Naming Color of 
Words – different) evaluates vigilance, selectivity of attention 
and executive control including the cognitive inhibition and 
monitoring of the performance, resistance to interference, 
as well as cognitive flexibility (Strauss et al. 2006, Badgaiyan 
and Posner 1998, Lezak et al. 2012). Neuroimaging results 
found the activation of the prefrontal cortex, cingulate 
cortex and other brain structures, including basal ganglia and 
cerebellum during the test performance (Badzakova-Trajkov 
et al. 2009, Tomaszewska et al. 2010).
The following parameters were assessed in the test: 
a) the time of performance of RCNb part (Stroop_I) 
and NCWd part (Stroop_II) in seconds – measures of 
psychomotor speed and attention; b) the time difference 
between performance on both parts of the test (Stroop_II-I) 
– linked with executive functions.
Genotyping
Genomic DNA was extracted from 10 ml of ethylene-
diaminetraacetic (EDTA) acid-anticoagulated venous blood 
using the salting out method (Miller et al. 1988). Twelve 
SNPs have been genotyped in the BDNF gene based on 
Real-Time PCR 7900HT Fast System with molecular TaqMan 
probes The description of analyzed polymorphisms is 
given in Table I. Real-Time PCR System allows performing 
Table I. Description of analyzed polymorphisms
SNP ID chromosomal positon MAF Alleles HWE TaqMan assay ID function
rs6265/Val66Met 27636492 0.17 G:A 0.75 C__11592758_10 exon
rs11030101 27637320 0.23 A:T 0.19 C___1751785_10 5’UTR
rs11030102 27638172 0.29 C:G 0.57 C__31701068_10 intron
rs1401635 27650567 0.37 C:G 0.02 C___8744367_10 intron
rs2049045 27650817 0.18 G:C 0.87 C__12035465_10 intron
rs10835210 27652486 0.36 C:A 0.11 C___1751795_10 intron
rs1013402 27668957 0.35 T:C 0.02 C___7468814_10 intron
rs2049046 27680351 0.40 A:T 0.20 C__12035467_10 intron
rs988748 27681321 0.22 C:G 1.805e-05 C___1197570_10 intron
rs2030324 27683491 0.43 T:C 0.26 C__12035468_20 intron
rs2030323 27685115 0.22 G:T 0.16 C__12035469_20 intron
rs2883187 27697668 NN C:T 0.30 C___1197561_10 5’UTR
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a risk analysis with the elimination of genotyping error. In 
addition, 10% of randomly selected samples were subjected 
to re-designation with nearly 100% compatibility. We 
used study by Petryshen and others (2009) to select gene 
variants for our investigation. 
Statistical analysis
The concordance of the distribution of genotypes 
with the Hardy-Weinberg equilibrium and linkage 
disequilibrium analysis was done using Haploview v.4.0 
program (Barrett et al. 2005, http://www.broadinstitute.
org/). We investigated possible relationship between 
haplotypes and neuropsychological tests performance in 
PLINK (Purcell et al. 2007, http://pngu.mgh.harvard.edu/
purcell/plink/). To determine haplotype blocks we used 
PLINK option: “plink --file mydat --blocks --out mydat 
--blocks”. To evaluate haplotype frequencies we used the 
following command: “plink --file mydat --hap bdnf-blocks.
blocks --hap-freq --out mydat” (Table II). To run association 
analyzes we used: 
“plink --file mydat --pheno cog-pheno.txt --pheno-
name TMT_A --hap TMT_A.blocks --hap-linear --mperm 
10000 --out TMT_A”. We investigated haplotype blocks for 
all phenotypes separately and then for the whole sample, 
as we got same results for all of them.
Table II. Haplotype frequencies
Locus Haplotype F
H1 TACGCCATAAG 0.176
H1 CTCGGAAAGCA 0.495
H1 CACGGCATAAG 0.029
H1 CACCGCGTACG 0.058
H1 CTCGGCAAGCA 0.022
H1 CAGCGCGTACG 0.189
Additionally, we explored how each single 
polymorphism influenced each cognitive outcome 
with generalized linear models (GLM) corrected for 
demographic covariates (i.e., age, sex and years of 
education), in (Statistica 10.0). In case of significant 
main effect for a given polymorphism, ANCOVA was 
complemented by contrast analysis for groups with 
different genotypes. 
We are aware that the problem connected with 
the multivariate analysis is an issue of multiple 
comparisons. In case of correlated phenotypes (e.g. 
cognitive performance measurements) the principal 
component analysis (PCA) may be conducted. However, 
the neuropsychological tests usually measure more than 
one aspect of cognitive functions. While using PCA we 
may lose detailed insight into specific test parameters, 
even if they are correlated. Moreover these parameters 
are often expressed in different values (i.e. percentage 
of errors, number of correct responses, reaction time). 
Taking those into account we decided not to conduct the 
PCA in our work.
RESULTS
HWE analysis
Genotype distribution for nine polymorphisms was in 
concordance with the Hardy-Weinberg equilibrium. Due 
to the deviation from HWE (p>0,05) three polymorphisms 
(rs1401635, rs1013402, rs988748) were excluded from 
further SNP analysis. 
In case of haplotypes analysis, HWE value was set 
as p>0,0000001 (Anderson et al. 2010). Therefore only 
polymorphism rs988748 was excluded from further 
analysis.
Polymorphisms and results of neuropsychological 
tests
Based on the obtained results, it can be concluded 
that among the considered measures of cognitive 
functions, only TMT A time performance was related 
to the BDNF polymorphisms included in the study, as 
follows (Table III):
1)  Polymorphism rs11030101: F2,437=4.157, P=0.016, 
η2p=0.019.
  The performance time of TT homozygotes was 
significantly longer compared to TA and AA 
genotypes (F1,437 =8.014, P<0.005).
 Age: F1,437 =110.152, P<0.001, η2p=0.201.
 Education: F1,437=2.250, P=0.134, η2p=0.005.
2)  Polymorphism rs10835210: F2,438=4.546, P=0.011, 
η2p=0.020.
  The performance time of AA homozygotes need 
was significantly longer compared to AC and CC 
genotypes (F1,438=8.855, P<0.003).
 Age: F1,438 =109.565, P<0.001, η2p=0.200.
 Education: F1,438=2.141, P=0.144, η2p=0.005.
3)  Polymorphism rs2049046: F2,437=3.784, P=0.023, 
η2p=0.017.
  The performance time of AA homozygotes was 
longer compared to AT and TT genotypes (F1,437=7.295, 
P<0.007).
 Age: F1,437=111.422, P<0.001, η2p=0.203.
 Education: F1,437=1.917, P=0.167, η2p=0.004.
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4)  Polymorphism rs2030324: F2,437=4.133, P=0.017, 
η2p=0.019.
  The performance time of GG homozygotes was 
significantly longer compared to GA and AA 
genotypes (F1,437=7.616, P<0.006).
 Age: F1,437=107.968, P<0.001, η2p=0.198.
 Education: F1,437=2.024, P=0.155, η2p=0.005.
5)  Polymorphism rs2883187: F2,438=4.183, P=0.016, 
η2p=0.019.
  The performance time of AA homozygotes was 
significantly longer compared to AG and GG 
genotypes (F1,438=7.816, P<0.005).
 Age: F1,438=109.143, P<0.001, η2p=0.199.
 Education: F1,438=2.066, P=0.151, η2p=0.005.
The performance on TMT_A was to a greater extent 
explained by age than polymorphisms. The size effect, 
as measured by the coefficient of the partial eta square 
of age variable was large in all cases, while effect 
for polymorphisms was small. Years of education 
have not explained a statistically significant results 
in TMT_A. In our study the relation between BDNF 
polymorphisms and TMT_A performance was neither 
modified by gender.
Haplotypes and results of neuropsychological tests
The analysis revealed one block of haplotype. Strong 
linkage disequilibrium was observed between 11 studied 
polymorphisms (Fig. 1). 
Table III. Results of TMT_A (in seconds) in groups with different genotypes
Polymorphism Genotype
rs11030101 TT TA AA
M (SD) 24.41 (9.00) 21.99 (7.10) 22.38 (7.75)
M adjusted 24.38 22.24 22.14
N 113 236 96
rs10835210 AA AC CC
M (SD) 24.68 (9.27) 21.93 (7.01) 22.50 (7.73)
M adjusted 24.61 22.28 22.18
N 101 242 103
rs2049046 AA AT TT
M (SD) 24.39 (8.88) 21.97 (7.21) 22.46 (7.50)
M adjusted 24.32 22.30 22.18
N 116 236 93
rs2030324 GG GA AA
M (SD) 24.40 (8.90) 21.87 (7.14) 22.59 (7.57)
M adjusted 24.36 22.22 22.31
N 121 233 91
rs2883187 AA AG GG
M (SD) 24.36 (8.94) 21.87 (7.14) 22.55 (7.54)
M adjusted 24.36 22.21 22.25
N 121 233 92
Fig. 1. Relative positions and LD estimates between polymorphisms. Colored 
squares correspond to D’values with numerical estimates given within squares.
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We found the association of haplotypes: CTCGGAAAGCA 
with a longer time of performance on TMT_A (F=0.495, 
B=1.12, t=4.26, P=0.034) and CACCGCGTACG with a shorter 
time of performance on TMT_B (F=0.058, B=−5.74, t=4.42, 
P=0.036). No association with other cognitive measures 
was observed.
DISCUSSION
Previous research on relations between the BDNF 
gene polymorphisms and cognition focus primarily on 
hippocampus-dependent cognitive domains, mainly on 
long-term memory and learning (Kambeitz et al. 2012). 
However, the influence of BDNF on brain structure and 
function was also observed in different cortical regions 
(Pezewas et al. 2004, Matsuo et al. 2009, Yang et al. 2012). In 
our study we concentrated on the relation between BDNF 
polymorphisms and haplotypes with neuropsychological 
measures engaging predominantly prefrontal cortex, 
an area associated with higher cognitive functions, 
such as working memory, executive attention, planning, 
set-shifting (Bath and Lee 2006).
The analysis of the associations between nine 
BDNF polymorphisms and the results of well-known 
neuropsychological tests (WCST, TMT and Stroop test) 
showed significant relationship between five of them and 
the performance on TMT_A. This task to the greatest extent 
is assessing psychomotor speed of attentional search of 
visual field. Psychomotor speed has been related to velocity 
of nerve conduction, speed of information processing and 
data retrieval from memory (Jensen 1993). It influence 
the efficacy of most cognitive domains (Lezak et al 2012). 
The BDNF polymorphisms were found to be related to 
psychomotor or processing speed in previous studies 
(Miyajima et al. 2008, Cathomas et al. 2010, Laing et al. 2012). 
In our study better results were recorded in homozygotes 
for the alleles with a higher frequency in the population for 
all five polymorphisms (rs11030101, rs10835210, rs2049046, 
rs2030324, rs2883187). Similarly, most of the studies of 
Val66Met found homozygotic Val/Val variant to be more 
beneficial for cognitive functioning in different cohorts 
(Egan et al. 2003, Rybakowski et al. 2006, Gong et al. 2009), 
except for elderly (Harris et al. 2006, Brooks et al. 2014) who 
however were not included in this study. 
Given that the examination of single polymorphism 
may result in overlooking some information, the analysis of 
haplotype was suggested to improve genotyping efficiency 
and assessment of gene effect on specific function (Hong et al. 
2011). In our study, we identified one block of haplotype and 
revealed the association of CTCGGAAAGCA haplotype with 
better results of TMT_A, confirming the impact of BDNF gene 
on psychomotor speed. In addition, it showed the relation 
of CACCGCGTACG haplotype with a worse performance on 
TMT_B. In previous study, better performance on TMT_B 
test was found to be associated with BDNF Met66 allele and 
connected with larger left cerebellum, right precuneus, left 
superior frontal gyrus and bilateral hippocampal volumes, 
while worse results on TMT were connected with larger 
brainstem and bilateral posterior cingulate cortex volumes 
in older adults (Brooks et al. 2014). 
TMT_B is considered as a tool to measure working memory 
and executive performance such as set-shifting, inhibition 
and cognitive flexibility (Marqués-Iturria et al. 2014). However 
we found no association between BDNF polymorphisms and 
haplotypes and other neuropsychological tests, i.e. WCST 
and Stroop, used to measure these cognitive domains. It is in 
line with the studies of Oral and others (2012) and Han and 
colleagues (2015), who also applied several tasks to measure 
executive functioning and similarly to us found association 
of BDNF serum level only with TMT_B. Our hypothesis is that 
it may be connected with the specificity of the task which 
applies psychomotor speed and visuo-perceptual abilities 
(Sanchez-Cubillo et al. 2009) It may be assumed that BDNF 
is related to executive performance through those cognitive 
abilities. 
Some research found BDNF genetic effect on cognition 
to be gender-specific (Matsuo et al. 2009, Raz et al. 2009, van 
Wingen et al. 2010, Laing et al. 2012). In our study the relation 
between BDNF polymorphisms and TMT_A performance 
was not modified by gender. It also needs to be noticed that 
size effect of polymorphisms on TMT_A performance was 
much smaller than the effect of age. In contrast to several 
studies (Hong et al. 2011, Kambeitz et al. 2012), the functional 
polymorphism Val66Met was found to have no relation with 
cognitive functions measured in our study. The number 
of inconsistent reports within the literature assessing the 
effects of the Val66Met polymorphism in both healthy and 
clinical samples emphasizes that phenotypic associations 
can be subtle and are susceptible to nuisance variance and 
noise. Additionally, differences in allelic frequency between 
populations, suggests ethnicity-specific effect of this variant 
(Notaras et al. 2015). The genetic influence on cognition may 
be also less pronounced in healthy subjects even in Caucasian 
populations which was shown to be more susceptible to the 
effect of the BDNF, whereas in clinical groups and in older 
subjects genotype may be an important factor mediating the 
ability of effective cognitive compensation.
CONCLUSIONS
In general, the results of our study has revealed the 
associations between BDNF polymorphisms and haplotypes 
with the results of TMT, a task considered to be connected 
with prefrontal cortex activity. However, we found no 
relations between BDNF and other neuropsychological tests 
engaging prefrontal area of the brain. We assumed that it 
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may be related to the visuo-motor specificity of the TMT. 
Our study confirms also the value of continued research 
employing neuropsychological assessment to enhance 
the knowledge of molecular mechanisms associated with 
cognition. 
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